Wondrous Roots Radio Notes - Breast Cancer Unawareness - Oct 21, 2017
CLICK ON THE DATE TO LISTEN!
SATURDAY, OCTOBER 21, 2017 – Becky continues her outrage with the frank deception of “Breast Cancer Awareness Month,” which is not about awareness at all but about funding the special interests – all of them – involved in the Cancer Factory of our healthcare system, which would crumble if cancer ever went away!
Ugh… Here we go again…
October – “Breast Cancer UN-awareness Month”
Time for your annual mammogram?
KEEP YOUR SHIRT ROLLED DOWN, AND JUST SAY “NO!”
WHY EVERYTHING YOU KNOW ABOUT CANCER IS WRONG
COVERING UP THE CAUSES OF BREAST CANCER SINCE 1985
DEVASTATING REPORT: CANCER MISDIAGNOSED IN OVER 1.3 MILLION CASES
MILLIONS WRONGLY TREATED FOR “CANCER” NATIONAL INSTITUTE PANEL CONFIRMS
CANCER INDUSTRY SCAM – NCI ADMITS TO TREATMENT OF MANY FALSE DIAGNOSES
DOES CANCER SCREENING SAVE LIVES?
HOW WE DO HARM – A DOCTOR BREAKS RANKS ABOUT BEING SICK IN AMERICA – Otis Webb Brawley, MD
CANCER DOCS PROFIT FROM CHEMOTHERAPY DRUGS – NBC NEWS
HOW MEDICARE SELF-REFERRAL THRIVES ON LOOPHOLE – WJS
HORMONE BALANCE: THE KEY TO BREAST CANCER PREVENTION
HYPOTHESIS: IODINE, SELENIUM, AND THE DEVELOPMENT OF BREAST CANCER – Cancer Causes and Control, 2000
BREAST CANCER PREVENTION WITH IODINE SUPPLEMENTATION – Jeffrey Dach, MD
“Iodine, a well-known topical antiseptic and antimicrobial agent, also directly kills cancer cells and serves as the key player in our body’s surveillance system for removing abnormal pre-cancer cells. There is considerable medical research to support this statement.”
Increased Rates of Chromosome Breakage in BRCA1 Carriers are Normalized by Oral Selenium Supplementation.
EATING IODINE-RICH FOODS AND BREAST CANCER PREVENTION
IODINE TREATS BREAST CANCER – OVERWHELMING EVIDENCE – Jeffrey Dach, MD
IODINE TREATS AND PREVENTS CANCER – Dr. Mark Sircus, Ac., OMD
CANNABINOID TREATMENTS VS. TRIPLE NEGATIVE BREAST CANCER
HOW A NEW TESTING KIT AFFECTS CANNIBIDIOL BREAST CANCER TREATMENT
"The estimated cost of mammography screening in the US in 2010 under actual practice was $7.8 billion, with approximately 70% of women participating. The simulated cost of screening the target of 85% of women was $10.1 billion for annual screening, $2.6 billion for biennial screening, and $3.5 billion for USPSTF guidelines. The largest drivers of cost (in order) were: screening frequency, percent women screened, cost of a mammogram, percent digital mammography, and percent women recalled." -
Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines